Health Affairs, 24, no. 1 (2005): 102-113 doi: 10.1377/hlthaff.24.1.102 © 2005 by Project HOPE	New Online   New Issue: China & India   Obesity In China   Pay Cuts For Medicare Docs   Access To Care Woes

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (13) Citing Articles via Google Scholar Google Scholar Articles by Atkins, D. Articles by Slutsky, J. Search for Related Content PubMed PubMed Citation Articles by Atkins, D. Articles by Slutsky, J. Related Collections Evidence-Based Medicine Health Reform Physicians Quality Of Care

Evaluating Evidence

Making Policy When The Evidence Is In Dispute

Policymakers often struggle with medical issues that are the subject of fierce scientific debate. On closer examination, many of these debates are manifestations of conflicting perspectives and values as much as disagreements over the evidence. We summarize common factors underlying recent debates and outline a series of questions that can help disentangle questions of evidence from those of values. These questions focus on identifying the most important outcomes, evaluating the quality of evidence, and assessing the trade-offs involved. We then use four recent policy debates—involving prostate-specific antigen (PSA) screening, high-dose chemotherapy for breast cancer, antibiotic therapy for otitis media, and newborn hearing screening—to illustrate how this approach can help clarify areas of agreement and disagreement of the opposing sides.

                      What's this?

This article has been cited by other articles:

				P. D. Jacobson Transforming Clinical Practice Guidelines Into Legislative Mandates: Proceed With Abundant Caution JAMA, January 9, 2008; 299(2): 208 - 210. [Full Text] [PDF]

				P. H. Arn Newborn Screening: Current Status Health Aff., March 1, 2007; 26(2): 559 - 566. [Abstract] [Full Text] [PDF]

				C. I. Kaye and and the Committee on Genetics Newborn Screening Fact Sheets Pediatrics, September 1, 2006; 118(3): e934 - e963. [Abstract] [Full Text] [PDF]

				P. J. Neumann Emerging Lessons From The Drug Effectiveness Review Project Health Aff., July 1, 2006; 25(4): W262 - W271. [Abstract] [Full Text] [PDF]

				R. R. Howell We Need Expanded Newborn Screening Pediatrics, May 1, 2006; 117(5): 1800 - 1805. [Full Text] [PDF]